Galapagos NV
GLPG
#4552
Rank
ยฃ1.58 B
Marketcap
ยฃ23.98
Share price
-0.69%
Change (1 day)
19.56%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -ยฃ0.18

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -ยฃ0.26. In 2024 the company made an earnings per share (EPS) of ยฃ0.88 a decrease over its 2023 EPS that were of ยฃ2.68.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.18-120.74%
2024ยฃ0.88-67.16%
2023ยฃ2.68-199.64%
2022-ยฃ2.6999.03%
2021-ยฃ1.35-68.98%
2020-ยฃ4.36-298.06%
2019ยฃ2.20-554.64%
2018-ยฃ0.48-77.18%
2017-ยฃ2.12-326.21%
2016ยฃ0.94-134.19%
2015-ยฃ2.75-371.34%
2014ยฃ1.01-445.98%
2013-ยฃ0.2932.88%
2012-ยฃ0.22-82.07%
2011-ยฃ1.23-817.9%
2010ยฃ0.1712.73%
2009ยฃ0.15-120.79%
2008-ยฃ0.73-37.67%
2007-ยฃ1.1739.64%
2006-ยฃ0.8428.17%
2005-ยฃ0.656.25%
2004-ยฃ0.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.42-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ2.84-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.81-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.56-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ5.53-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ4.05-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ2.85-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-ยฃ0.46 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.94-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel